|
WDR44 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.781200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.409600E-01 |
| Normal-vs-Stage2 |
2.876200E-02 |
| Normal-vs-Stage3 |
1.908840E-01 |
| Normal-vs-Stage4 |
2.723800E-01 |
| Stage1-vs-Stage2 |
2.819700E-02 |
| Stage1-vs-Stage3 |
2.364200E-01 |
| Stage1-vs-Stage4 |
3.478800E-01 |
| Stage2-vs-Stage3 |
2.068200E-01 |
| Stage2-vs-Stage4 |
3.039800E-01 |
| Stage3-vs-Stage4 |
9.604800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.983200E-01 |
| Normal-vs-AfricanAmerican |
5.691400E-01 |
| Normal-vs-Asian |
8.033200E-01 |
| Caucasian-vs-AfricanAmerican |
3.223600E-01 |
| Caucasian-vs-Asian |
7.500400E-01 |
| AfricanAmerican-vs-Asian |
5.401800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.645700E-02 |
| Normal-vs-Female |
4.796800E-01 |
| Male-vs-Female |
1.832800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.058800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.200040E-01 |
| Normal-vs-Age(61-80Yrs) |
2.360300E-02 |
| Normal-vs-Age(81-100Yrs) |
4.348600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.194300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.056300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.712400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.856200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.762400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.138800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.680400E-01 |
| Classical-VS-Follicular |
9.96350000281865E-08 |
| Classical-VS-Other |
7.664400E-02 |
| Classical-VS-Normal |
6.118600E-01 |
| Tall-VS-Follicular |
2.918200E-03 |
| Tall-VS-Other |
1.152180E-01 |
| Tall-VS-Normal |
9.751200E-01 |
| Follicular-VS-Other |
9.535400E-01 |
| Follicular-VS-Normal |
2.399100E-04 |
| Other-VS-Normal |
5.916400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.910090E-02 |
| Normal-vs-N1 |
2.171400E-01 |
| N0-vs-N1 |
6.683800E-01 |
|
|
